An AlFu MOF nanoadjuvant functionalized with mannose for potential dendritic-cell targeting and dual TLR9–STING activation
DCC@M@AlFu‑MOF is an aluminum‑based nanoadjuvant with potential dendritic cell‑targeting ability. It can coordinate innate immune signaling and shows promise for enhancing vaccine‑induced immune responses.
Authors
- Yifan Sun (ORCID: https://orcid.org/0000-0002-4082-5379)
- Yi Guan (ORCID: https://orcid.org/0000-0002-1944-1610)
- Xiao Zhi
- Weixia Li
Institutions
- Shanghai Jiao Tong University (CN)
Publication Details
- Journal
- Nanomedicine
- Published
- 2026-01-14
- DOI
- https://doi.org/10.1080/17435889.2026.2614568
- Primary Topic
- interferon and immune responses
- Type
- article
- Field-Weighted Citation Impact
- 0.00